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Summary
A total of 360 weanling pigs (initially
12.3 lb BW and approximately 18 d of age)
was used in a 14-d growth assay to deter-
mine the optimal isoleucine:lysine ratio to
maximize growth performance.  The 12
experimental treatments consisted of either
1.00 or 1.26% apparent digestible lysine with
isoleucine concentrations of 45, 50, 55, 60,
or 65% of lysine.  Two positive control diets
were used with 1.10 and 1.39% apparent
digestible lysine and 45% isoleucine:lysine
to ensure that lysine was not the first limiting
amino acid in the basal diets. The results of
this experiment indicate that the optimal
apparent digestible isoleucine:lysine ratio for
the SEW pig is between 50 and 55% of
apparent digestible lysine.
(Key Words:  Isoleucine, Lysine, Weanling
Pigs.)
Introduction
Nutrient profiles of ingredients and
amino acid requirements vary between the
1988 and 1998 NRC publications.  These
changes have resulted in an increase in the
isoleucine requirement for the early-weaned
pig.  The current NRC requirements of ap-
parent digestible lysine and isoleucine for a
6 to 11 lb pig are 1.26% and .69% of the
diet, respectively, suggesting an apparent
digestible isoleucine:lysine ratio of 55%.
Recent changes in starter diets have resulted
in increased levels of blood meal or blood
cells being used as highly digestible protein
sources for weanling pigs.  However, these
products contain a lower concentration of
isoleucine than other protein sources.  The
objective of this experiment was to deter-
mine the appropriate apparent digestible
isoleucine:lysine ratio necessary to optimize
performance of the SEW pig.
Procedures
Three hundred and sixty weanling pigs
(initially 12.3 lb BW and approximately 18
d of age, PIC C22 × 327) were used in a 14-d
growth assay.  Pigs were blocked by initial
weight and allotted randomly to each of the
12 dietary treatments.  Each treatment had
six replications (pens) and five pigs per pen.
Corn, soybean meal, spray-dried plasma,
blood meal, fish meal, and spray-dried whey
were analyzed for complete amino acid
profiles prior to diet formulation based on
apparent digestible amino acid composition
of those ingredients.  The 12 experimental
treatments consisted of two basal diets (Ta-
ble 1) containing 1.00 and 1.26% apparent
digestible lysine with .45 and .57%
isoleucine, respectively, and all other amino
acids except isoleucine (Table 2) formulated
to 110 % of the recommended NRC require-
ments.  Crystalline isoleucine then was
added to each of the basal diets to meet the
desired level of each treatment (50, 55, 60,
and 65% of lysine).  Lysine was added to
two positive controls to provide 1.10 and
1.39% apparent digestible lysine and ensure
that lysine was not the first limiting amino
acid.  All diets were fed in pellet form.
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Pigs were housed in an environmentally
controlled nursery.  Temperature was main-
tained at 90° F for the first week and reduced
to 85°F for the second week.  Each pen (4 ×
4 ft) contained a stainless steel self-feeder
and one nipple waterer to allow ad libitum
consumption of feed and water. 
Table 1. Basal Diet Composition (As-Fed
Basis)a
Apparent Digestible
Lysine, %
Ingredient 1.00 1.26
Corn 33.90 42.69
Cornstarchb 14.00 .25
Lactose 12.66 10.50
Dried whey 12.00 15.00
Soybean meal (46.5% CP) 6.04 7.92
Choice white grease 5.00 5.00
Spray-dried blood plasma 4.40 5.50
Select menhaden fish meal 4.00 5.00
Spray-dried blood cells 3.20 4.00
Monocalcium phosphate 2.59 1.56
Medicationc 1.00 1.00
Zinc oxide .37 .37
Limestone  — .33
Vitamin premix .25 .25
Salt .20 .20
Trace mineral premix .15 .15
DL-Methionine .08 .09
L-threonine .07 .08
Sow add pack .05 .05
Cystine .02 .03
L-Isoleucine .02 .03
aDiets were formualted to 45% isoleucine:lysine
with all other amino acids at 110% of NRC
requirements.
bL-Isoleucine replaced cornstarch in the 1.00 and
1.26% apparent digestible lysine basal diets to
provide .45, .50, .55, .60, and .65% apparent
digestible isoleucine and .567, .63, .693, .756, and
.819% apparent digestible isoleucine, respectively.
This provided apparent digestible isoleucine:lysine
ratios of 45, 50, 55, 60, and 65% at both lysine
levels.
cProvided 50 g/ton carbadox.
Experimental treatment diets were fed
from d 0 to 14 postweaning.  Pigs were
weighed and feed disappearance measured
on d 7 and 14 of the experiment to determine
ADG, ADFI, and F/G.  Blood samples were
obtained on d 10 from two randomly selected
pigs in each pen.  Feeders were removed 3
hours prior to blood collection.  Plasma urea
nitrogen (PUN) was determined on each
sample.  Plasma from pigs in the same pen
were pooled and analyzed for amino acid
profiles. 
Data were analyzed in a randomized
complete block design using the general
linear model (GLM) procedures of SAS with
pen as the experimental unit.  Linear and
quadratic polynomial contrasts were
performed to determine the effects of
increasing levels of dietary isoleucine.
Results and Discussion
No isoleucine × lysine interactions were
observed (P>.47) from d 0 to 7 (Table 3).
Increasing the apparent digestible
isoleucine:lysine ratio improved ADG,
ADFI, and F/G (linear and quadratic, P<.01)
from d 0 to 7.  The greatest response
occurred as the isoleucine:lysine ratio
increased from 45 to 50%, and a smaller
incremental improvement occurred as the
ratio increased from 50 to 55%.  Pigs fed the
diet containing 1.26% apparent digestible
lysine had better ADG than pigs fed 1.00%
apparent digestible lysine (P<.03).  From d 0
to 7, growth performance of pigs fed the
positive control diets was not different
(P>.05) than that of pigs fed the negative
control diets.  This confirms that isoleucine
was first limiting during this phase.
From d 7 to 14, lysine × isoleucine
interactions were observed for ADG and
ADFI. At either dietary lysine level,
increasing apparent digestible isoleucine
improved (linear and quadratic, P<.01)
ADG, ADFI, and F/G.  However, ADG
appeared to be maximized at 55% isoleucine
in diets containing 1.00% apparent digestible
lysine, whereas pigs fed 1.26% apparent
digestible lysine maximized ADG at
approximately 50% isoleucine.  Pigs fed the
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diet containing 1.26% apparent digestible
lysine had better (P<.01) ADG and F/G
compared to pigs fed 1.00% apparent
digestible lysine.  Pigs fed the positive
control diet containing 1.39% apparent
digestible lysine had better growth
performance (P<.06) from d 7 to 14
compared to pigs fed 1.26% apparent
digestible lysine.  This suggests that lysine
was becoming colimiting in the diet with
isoleucine.
From d 0 to 14, an isoleucine × lysine
interaction (P<.06) was observed for ADFI.
Pigs fed 1.00% apparent digestible lysine
obtained optimal feed intake at 55%
isoleucine; however, those fed 1.26%
apparent digestible lysine achieved
maximum feed intake at 50% isoleucine.
The greatest response to increasing levels of
isoleucine occurred as the apparent digestible
isoleucine:lysine ratio increased from 45 to
50%, and further numeric improvements
occurred as the ratio increased from 50 to
55% at the 1.00% apparent digestible level.
Feeding 1.26% apparent digestible lysine
improved (P<.02) ADG and F/G from d 0 to
14.  Overall, the positive control fed 1.39%
apparent digestible lysine had better (P<.02)
ADG and F/G compared to pigs fed 1.26%
apparent digestible lysine.  This suggests that
lysine was colimiting with isoleucine in the
1.26% apparent digestible lysine diet.
The plasma isoleucine concentration
increased (linear, P<.01) with increasing
dietary isoleucine (Table 4).  The greatest
response occurred as the isoleucine:lysine
ratio increased from 50 to 55%.  The plasma
lysine concentration tended to decrease
(quadratic, P<.07) as the ratio of isoleucine:
lysine approached the pigs’ requirement.
This suggests that lysine was used more
efficiently when the isoleucine:lysine ratio
was not deficient or in excess of the level
needed to obtain optimal growth.  The
greatest response with 1.00% apparent
digestible lysine occurred as the
isoleucine:lysine ratio increased from 50 to
55%; however, the greatest response at
1.26% lysine occurred as the ratio increased
from 45 to 50%. 
We then used break-point analysis to
determine the isoleucine requirement.  The
broken-line method, which predicts
requirements for the average animal in the
population, predicted requirements of
approximately 55% isoleucine:lysine at
1.00% apparent digestible lysine and
approximately 50% isoleucine:lysine at
1.26% apparent digestible lysine to achieve
optimal growth performance (Table 5).
Calculation of the daily isoleucine intake
requirement, using NRC 1998 equations
based on actual BW and performance of all
pigs in this experiment, estimated average
requirements of 1.2 g/d isoleucine from d 0
to 7 and 2.3 g/d from d 7 to 14.  The
calculated isoleucine intake requirements
that correlated with 55% isoleucine:lysine at
1.00% apparent digestible lysine were 1.2
g/d for d 0 to 7 and 2.5 g/d for d 7 to 14.  The
calculated requirements with 50%
isoleucine:lysine at 1.26% apparent
digestible lysine were 1.4 g/d for d 0 to 7 and
2.5 g/d for d 7 to 14.
Based on the results of this experiment,
the optimal apparent digestible  isoleucine:
lysine ratio for the 15 lb SEW pig is between
50 to 55% of apparent digestible lysine.
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Table 2. Calculated Composition of Control Dietsa,b, %
Apparent Digestible Lysine, %
1.00 1.26
Item, % Total Digestible Total Digestible
CP (N × 6.25) 16.12 — 20.35 —
Threonine .81 .66 1.02 .83
Valine .93 .79 1.17 .99
Methionine .34 .30 .42 .37
Isoleucine .53 .45 .67 .57
Leucine 1.61 1.40 2.02 1.77
Tyrosine — — — —
Phenylalanine .83 .71 1.04 .90
Histidine .56 .50 .71 .63
Lysine 1.17 1.00 1.47 1.26
Arginine .85 .75 1.07 .95
Tryptophan .25 .21 .32 .27
Ca, % .90 — .90 —
P, % .88 — .80 —
aValues were calculated from analyzed composition of corn, soybean meal, spray-dried
plasma, blood meal, menhaden fish meal, and spray-dried whey.
bAll amino acids in the positive control diets were the same with the exception of increased
levels of lysine.
Table 3. Effects of Isoleucine:Lysine Ratio on Growth Performance of the Early-Weaned Pig
Apparent Digestible Lysine, %
1.00 1.26 1.10 1.39
Isoleucine, % of Lysine Probability (P<)
Item 45 50 55 60 65 45 50 55 60 65 45 45 SEM Iso*Lys Lys Iso Linear Quad
Day 0 to 7
  ADG, lb 0.17 0.26 0.32 0.33 0.30 0.19 0.35 0.35 0.34 0.37 0.16 0.23 0.02 0.62 0.03 0.01 0.01 0.01
  ADFI, lb 0.26 0.31 0.35 0.39 0.35 0.27 0.39 0.38 0.35 0.37 0.27 0.27 0.02 0.47 0.27 0.01 0.01 0.01
  F/G 1.67 1.32 1.10 1.20 1.17 1.49 1.13 1.08 1.07 1.07 1.51 1.22 0.10 0.97 0.15 0.01 0.01 0.01
Day 7 to 14
  ADG, lb 0.38 0.50 0.64 0.63 0.58 0.40 0.71 0.64 0.75 0.65 0.34 0.55a 0.02 0.04 0.01 0.01 0.01 0.01
 ADFI, lb 0.52 0.64 0.79 0.78 0.78 0.49 0.79 0.73 0.81 0.70 0.52 0.58b 0.02 0.01 0.87 0.01 0.01 0.01
 F/G 1.39 1.27 1.23 1.23 1.34 1.27 1.12 1.14 1.08 1.08 1.46 1.06a 0.03 0.29 0.01 0.01 0.01 0.01
Day 0 to 14
  ADG, lb 0.27 0.38 0.48 0.48 0.44 0.29 0.53 0.50 0.54 0.51 0.25 0.39a 0.02 0.12 0.02 0.01 0.01 0.01
 ADFI, lb 0.39 0.48 0.57 0.58 0.56 0.38 0.59 0.56 0.58 0.54 0.39 0.43 0.02 0.06 0.47 0.01 0.01 0.01
 F/G 1.45 1.27 1.17 1.21 1.28 1.33 1.12 1.12 1.08 1.06 1.44 1.10a 0.03 0.48 0.01 0.01 0.01 0.01
Day 10
  PUN, mg/dL 3.74 2.82 3.44 2.49 2.19 5.19 4.32 5.76 4.88 3.31 2.87 6.61a 0.51 0.64 0.01 0.01 0.01 0.14
Initial BW, 12.3 lb.
aContrast vs 45% Iso at 1.26% Lysine (P<.02).
bContrast vs 45% Iso at 1.26% Lysine (P<.06).
Table 4. Effects of Isoleucine:Lysine Ratio on Plasma Amino Acid Profile of the Early-Weaned Pig
Apparent Digestible Lysine, %
1.00 1.26 1.10 1.39
Isoleucine, % of Lysine Probability (P<)
Item 45 50 55 60 65 45 50 55 60 65 45    45    SEM Iso*Lys Lys Iso Linear Quad
Threonine 264 270 282 335 273 237 256 291 300 364 253 397a 31.3 0.38 0.82 0.18 0.02 0.85
Valine 307 310 290 326 281 297 311 328 316 308 240b 329 19.4 0.69 0.48 0.77 0.92 0.31
Methionine 51 52 43 40 43 61 51 55 53 46 37b 42a 4.5 0.47 0.01 0.13 0.01 0.66
Isoleucine 28 29 53 74 76 42 40 69 77 105 32 30 8.4 0.73 0.01 0.01 0.01 0.41
Leucine 216 204 195 211 182 205 222 218 213 202 158b 208 13.6 0.72 0.27 0.62 0.26 0.41
Tyrosine 92 95 81 83 80 100 87 92 80 96 75 121 7.6 0.53 0.36 0.41 0.14 0.28
Phenylalanine 79 85 82 77 75 83 73 87 77 77 64 79 6.0 0.57 0.95 0.65 0.35 0.54
Tryptophan 36 43 34 36 39 39 35 34 32 42 36 50a 2.7 0.21 0.46 0.09 0.93 0.05
Lysine 115 129 73 90 74 115 87 90 79 134 194b 262a 17.0 0.06 0.65 0.17 0.21 0.07
Histidine 101 95 85 83 75 101 86 82 80 74 72b 72a 6.6 0.97 0.47 0.01 0.01 0.50
Arginine 64 72 67 68 70 77 75 91 92 110 63 89 10.3 0.56 0.01 0.48 0.07 0.78
aContrast vs 45% Iso at 1.26% Lysine (P<.05).
bContrast vs 45% Iso at 1.00% Lysine (P<.05).
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Table 5. Predicted Isoleucine:Lysine Ratio from Break-Point Analysis
Apparent Digestible Lysine, %
1.00 1.26
Item Two-Slopea One-Slopeb Two-Slopea One-Slopeb
Day 0 to 7
   ADG, lb 53.83 53.15 49.59 50.10
   ADFI, lb 60.47 57.04 49.72 49.14
   F/G 53.03 52.33 50.66 50.79
Day 7 to 14
   ADG, lb 56.20 54.86 49.56 49.29
   ADFI, lb 55.00 55.00 49.89 49.16
   F/G 53.24 50.14 48.17 50.67
Day 0 to 14
   ADG, lb 54.87 53.94 49.67 49.75
   ADFI, lb 56.36 55.00 49.89 49.37
   F/G 53.40 51.39 49.26 50.79
Plasma amino acids
   Isoleucine 42.32 61.76 48.73 —
   Lysine 47.42 55.63 53.00 47.84
aY = L + U(R–XLR) + V(XGR–R), where L = the ordinate of the break point in the curve, R
= the abscissa of the break point in the curve (the requirement estimate); XLR = a value of
X less than R; XG R  = a value of X greater than R; U = the slope of the line for X less than
R; V = the slope of the line for X greater than R.
bY = L +U(R–XLR), where L = the ordinate of the break point in the curve, R = the abscissa
of the break point in the curve (the reqirement estimate); XLR = a value of X less than R; U
= the slope of the line for X less than R.
